After completing his PhD on gene regulation in Germany in 1993, Thomas Grewal studied lipoprotein receptors during postdoctoral fellowships at the Heart Research Institute (HRI, Sydney) and the Clinical Research Institute (Montreal, Canada). From 1997–2003, Thomas Grewal led a research group at the University Hospital Eppendorf (Hamburg, Germany) and later (2003–2007) at the Centre for Immunology (CFI, St Vincent’s Hospital, Sydney). Thomas Grewal joined the School of Pharmacy in October 2007. His research examines the link between membrane transport and cell signaling, which regulates spatiotemporal signaling in health and disease. Utilizing a multi-disciplinary approach involving biochemistry, molecular cell biology, and state-of-the-art microscopy, he has developed expertise in scaffolding proteins and cellular cholesterol transport, which coordinates the localization/activity of signaling complexes and receptors.